Jiangsu Nanfang Medical Co., Ltd.SSE: 603880

Announcement on Expected Loss in Performance for 2025

Jan 31, 2026 · Issued by Jiangsu Nanfang Medical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 31, 2026

On 6ix: 6ix.com/news/announcement-on-expected-loss-in-performance-for-2025-132

Announcement on Expected Loss in Performance for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Jiangsu Nanfang Medical Co., Ltd. on 6ix

Earlier from Jiangsu Nanfang Medical

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026Jan 29
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business LicenseJan 24
Notice on Convening the 2nd Extraordinary General Meeting in 2026Jan 13
Announcement on Election of Employee Directors for the 5th Board of DirectorsDec 26, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025Dec 10, 2025

Later from Jiangsu Nanfang Medical

Announcement on Resignation of the Company's Director and Chief Financial Officer and Appointment of the General Manager to Perform the Duties of the Chief Financial OfficerMar 31
Announcement on Release of Pledge of Partial Shares of Controlling ShareholdersApr 18
Announcement on Application for Comprehensive Credit Line from Banks and Other Financial Institutions and Provision of Guarantee in 2026Apr 30
Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026May 9
Announcement on Resolutions of the 2025 Annual General MeetingMay 21

All Jiangsu Nanfang Medical news releases

Follow Jiangsu Nanfang Medical into a list and get an email when it puts out news.

Follow Jiangsu Nanfang Medical